GNGBF 股息： Getinge AB (publ) 收益洞察

Q: Getinge AB (publ) 的关键财务报表是什么？

根据最新的财务报表（Form-10K），Getinge AB (publ) 的总资产为 $63,918，净利润为 $1,638

Q: GNGBF 的关键财务比率是什么？

Getinge AB (publ) 的流动比率是 2.06，净利 margin 为 4.71，每股销售为 $127.61。

Q: Getinge AB (publ) 的收入按细分市场或地理位置如何划分？

Getinge AB (publ) 最大收入来源是 Acute Care Therapies，在最近的收益报告中收入为 16,529,000,000。就地区而言， United States 是 Getinge AB (publ) 的主要市场，收入为 11,697,000,000。

Q: Getinge AB (publ) 是否盈利？

是的，根据最新的财务报表，Getinge AB (publ) 的净利润为 $1,638

Q: Getinge AB (publ) 有负债吗？

是的，Getinge AB (publ) 的负债为 30,913

Q: Getinge AB (publ) 的流通股有多少？

Getinge AB (publ) 的总流通股为 272.36

主页

股票

GNGBF

GNGBF 财务

Getinge AB (publ)

$24.75

截至今日：Jan 27, 14:06:17 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$24.75

开盘价

$20.22

当日区间

$20.22 - $24.75

52周范围

$18.54 - $24.75

交易量

300

平均成交量

每股收益（TTM）

0.82

股息收益率

市值

$6.2B

什么是 Getinge AB？

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 11,794 full-time employees. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

功能特性

交易策略

资源

市场

收入

资产负债表

现金流量

年度

季度性

GNGBF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	35,855	34,759	31,827	28,292	27,049	29,819
营收同比增长 (YoY)	7%	9%	12%	5%	-9%	12%
营收成本	18,652	18,309	17,332	14,882	13,469	15,097
毛利润	17,203	16,450	14,495	13,410	13,580	14,722
销售、一般及管理费用	9,726	9,594	8,704	7,484	6,972	7,596
研发	1,310	1,332	1,131	1,013	804	770
营业费用	12,423	11,967	10,348	9,527	9,113	9,761
其他非经营性收入 (费用)	--	-155	-24	-23	-41	-42
税前利润	2,849	2,282	3,343	3,472	4,188	4,485
所得税费用	775	628	915	956	1,187	1,213
净利润	2,054	1,638	2,412	2,491	2,970	3,239
净利润增长	21%	-32%	-3%	-16%	-8%	165%
稀释后流通股数	272.37	272.37	272.37	272.37	272.37	272.36
股份同比变动 (YoY)	0%	0%	0%	0%	0%	0%
每股收益 (摊薄)	7.54	6.01	8.85	9.14	10.9	11.89
每股收益增长率	21%	-32%	-3%	-16%	-8%	165%
自由现金流	3,137	3,268	1,604	2,231	5,630	6,154
每股自由现金流	--	--	--	--	--	--
毛利率	47.97%	47.32%	45.54%	47.39%	50.2%	49.37%
营业利润率	13.33%	12.89%	13.02%	13.72%	16.51%	16.63%
净利率	5.72%	4.71%	7.57%	8.8%	10.98%	10.86%
自由现金流利润率	8.74%	9.4%	5.03%	7.88%	20.81%	20.63%
EBITDA	7,311	6,904	6,240	5,910	6,281	7,428
EBITDA 利润率	20.39%	19.86%	19.6%	20.88%	23.22%	24.91%
EBITDA 中的折旧与摊销	2,531	2,421	2,093	2,027	1,814	2,467
EBIT	4,780	4,483	4,147	3,883	4,467	4,961
EBIT 利润率	13.33%	12.89%	13.02%	13.72%	16.51%	16.63%
有效税率	27.2%	27.51%	27.37%	27.53%	28.34%	27.04%

Follow-Up Questions

Getinge AB (publ) 的关键财务报表是什么？



GNGBF 的关键财务比率是什么？



Getinge AB (publ) 的收入按细分市场或地理位置如何划分？



Getinge AB (publ) 是否盈利？



Getinge AB (publ) 有负债吗？



Getinge AB (publ) 的流通股有多少？



Getinge AB (publ)（GNGBF）价格

GNGBF 股价走势图